Chiral integrin modulators and methods of use thereof
US7045663B2 · kind B2 · utility
1Cited by
22References
54Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 10, 2001 |
| Grant date | May 16, 2006 |
| Priority date | — |
| Expiry date | Nov 1, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C323/65
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides enantiomers of ajoene and derivtives of Z(−)-ajoene. The derivative of Z(−)-ajoene are useful for modulating integrin-mediated functions, for treating disorders, diseases or conditions in which integrins play a role, and for treating tissues to improve their condition for a subsequent use, such as transplantation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.